DZ Bank
BBIO icon

DZ Bank’s BridgeBio Pharma BBIO Stock Holding History

DZ Bank’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.31M Sell
125,053
-14,457
-10% -$1.01M 0.01% 410
2026
Q1 		$10.4M Buy
139,510
+48,755
+54% +$3.53M 0.01% 376
2025
Q4 		$6.94M Sell
90,755
-35,204
-28% -$2.31M 0.01% 443
2025
Q3 		$6.54M Buy
125,959
+87,739
+230% +$4.28M 0.01% 472
2025
Q2 		$1.65M Buy
+38,220
New +$1.39M ﹤0.01% 619

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

DZ Bank's BBIO Position: Q2 2026 in Review

DZ Bank reduced its BridgeBio Pharma (BBIO) stake by 10% in Q2 2026, selling an estimated $1.01M and leaving 125,053 shares worth $9.31M. The position accounts for 0.01% of the portfolio, ranked #410.

DZ Bank first reported a position in BBIO in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.4M in Q1 2026. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • DZ Bank held 125,053 shares of BridgeBio Pharma worth $9.31M as of Q2 2026.
  • DZ Bank sold 14,457 BridgeBio Pharma shares in Q2 2026, an estimated $1.01M.
  • BridgeBio Pharma made up 0.01% of DZ Bank's portfolio in Q2 2026, its #410 holding.
  • DZ Bank first reported a position in BridgeBio Pharma in Q2 2025 and has held it in 5 quarters since.
  • DZ Bank's BridgeBio Pharma position peaked at $10.4M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.